Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 7/2022

Open Access 01.02.2022 | Original Article

Predictive value of neutrophil to lymphocyte ratio on acute kidney injury after on-pump coronary artery bypass: a retrospective, single-center study

verfasst von: Zhang Guangqing, Cheng Liwei, Ling Fei, Zheng Jianshe, Zeng Guang, Zhu Yan, Cao Jianjun, Tian Ming, Chen Hao, Liu Wei

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 7/2022

Abstract

Objective

To investigate the predictive value of preoperative neutrophil to lymphocyte ratio (NLR) on acute kidney injury (AKI) after on-pump coronary artery bypass (ONCAB).

Methods

Patients who underwent elective ONCAB for coronary heart disease were included. NLR was calculated according to the results of preoperative routine blood test, patients were divided into non-AKI and AKI groups, and the differences in clinical baseline data between the two groups were compared.

Results

A total of 154 patients were included in this study, including 57 (37%) with postoperative AKI and 97 (63%) without AKI. Compared with the patients in non-AKI group, those in AKI group had higher NLR (2.63 (1.83, 3.505) vs. 2.06 (1.7, 2.56), p = 0.002), higher serum creatinine (78 (67, 98.5) vs. 70.9 ± 16.8 umol/L, p < 0.001), longer cardiopulmonary bypass time, and longer aortic cross clamp time. After dividing patient into tertiles based on NLR, those with higher NLR had higher risk of postoperative AKI than those with lower NLR (30% vs. 25% vs. 55.8%, p for trend = 0.003). Patients in Tertile2 and Tertile3 had higher NLR compared to those in Tertile1 (p < 0.05); multivariate logistic regression analysis showed patients with elevated preoperative NLR and blood creatinine had higher risk of postoperative AKI. ROC curve showed that patients’ preoperative NLR combined with blood creatinine had better predictive value for postoperative AKI.

Conclusion

Elevated preoperative NLR is associated with AKI after ONCAB, and had prognostic utility independent of other recognized risk factors.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s11748-022-01772-z.
Zhang Guangqing, Cheng Liwei and Ling Fei are equal contributors.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Globally, coronary heart disease is the most common cause of death [1]. Coronary artery bypass grafting (CABG) remains the mainstay of treatment for patients with severe multivessel disease, especially for those combined with left main stem lesions in coronary artery disease, in which CABG can reconstruct blood flow and relieve myocardial ischemic and hypoxic symptoms. Despite the great improvements in surgical approaches and supervised treatment in cardiac surgery, the incidence and mortality associated with acute kidney injury (AKI) has not been significantly reduced in recent years [2]. Several studies have shown that AKI is a common complication after CABG, up to 5–30%, of which 1–2% of patients may require renal replacement therapy [3]. AKI contributes to patients’ increased complication rates and morbidity and mortality, prolonged hospital stays and increased medical costs [4]. Even a slight increase in postoperative blood creatinine may increase morbidity and mortality [5]. AKI after cardiac surgery is closely related to inflammation, ischemia and reperfusion injury, neurohormonal activation, and oxidative stress [6]. Therefore, early warning and identification of patients at high risk of AKI after CABG is extremely important to guide individualized treatment and improve patient prognosis. Lymphocyte apoptosis is a prevalent phenomenon in the inflammatory response, and neutrophils as phagocytic cells are involved in the complex mechanisms regulating inflammatory and immune responses in the organism. In inflammatory states, neutrophil to lymphocyte ratio (NLR) can better reflect to the various intercellular imbalance in the body. Studies showed that NLR had the positive correlation and synchronous changes with various classical inflammatory indices, indicating the state of renal function during the inflammation and disease processes [7]. However, existing studies have shown the conflicting predictive value of preoperative NLR for postoperative AKI in patients undergoing CABG alone [6, 8]. In this study, we aimed to investigate the correlation between preoperative NLR and postoperative AKI after ONCAB, and the combined predictive value of preoperative NLR with other indicators.

Materials and methods

Study population

Patients undergoing ONCAB for coronary artery disease at Sinopharm Dongfeng General Hospital from October 2016 to June 2021 were retrospectively analyzed. All patients underwent CABG under mild hypothermia cardiopulmonary bypass. Myocardial protection was performed in all cases by intermittent antegrade perfusion of cold blood cardioplegic solution. Extracorporeal rewarming was started after completion of proximal anastomosis and stopped when nasopharyngeal temperature reached 36–37 °C, rectal temperature reached 35–36 °C, hemoglobin ≥ 80 g/L, and hematocrit ≥ 24%. A single aortic cross clamp (ACC) technique was used in all cases.
Inclusion criteria (1) age ≥ 18 years; and (2) diagnosis confirmed by cardiac ultrasound and coronary angiography, with clear indications for CABG.
Exclusion criteria (1) incomplete clinical data; (2) preoperative renal replacement therapy or maintenance hemodialysis; (3) simultaneous cardiac combined renal surgery; (4) preoperative infectious status or history of AKI within the past 3 months; (5) chronic autoimmune disease with hormone therapy; (6) severe heart failure; (7) renal transplantation; and (8) postoperative death.

Methods

Baseline clinical data were collected from all eligible patients, including gender, age, underlying disease, comorbidities, surgical approach, intraoperative recording of cardiopulmonary bypass time, ACC time, changes in blood creatinine and urine volume during the 7 days after surgery, and preoperative laboratory tests [blood routine test and NLR, blood type, coagulation function, liver and kidney function, blood lipids, brain natriuretic peptide (BNP), troponin, and left cardiac ejection fraction (LVEF) assessed by echocardiography].
Relevant definitions: (1) the diagnosis of chronic kidney disease was referred to the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines [9]. (2) AKI was diagnosed according to the modified KDIGO guidelines [10] by meeting any of the following: (i) rapid decline in renal function within 48 h after surgery with an absolute increase in serum creatinine ≥ 26.5 umol/L (0.3 mg/dl); (ii) increase in serum creatinine to ≥ 1.5 times the basal value at 7 days; (iii) urine volume < 0.5 mL/(kg h) with duration > 6 h.

Statistics

Continuous normal distribution variables were expressed as mean ± standard deviation in each subgroup. The two samples were compared by independent sample t test; continuous variables of non-normal distribution were expressed as median concentration and quartile distance. Mann–Whitney U test is used for the comparison between the two groups, and Kruskal–Wallis h test is used for the comparison between multiple groups. Categorical variables were expressed as percentage, and the chi-square test was used for the comparison between groups. The analysis of linear trends was used to assess the correlation between increasing the NLR levels and risk of AKI after the sample was divided into tertiles based on the distribution of controls. Multivariate logistic regression analysis was used to further analyze the correlation between NLR and AKI. The best cut-off value of NLR for predicting AKI was analyzed by receiver operating characteristic (ROC) curve. Differences with a p value of < 0.05 (two-tailed) were considered to be statistically significant. Analysis was performed using R version 3.6.0. GraphPad prism 8 and Photoshop version 6.0 software are used for graphic production.

Results

Characteristics of enrolled patients

According to the inclusion and exclusion criteria, 154 patients were finally included in this study. Among them, 66.9% were male and 33.1% were female; 34.4% cases were under 60 years old and 65.6% were over 60 years old. 37% patients had previous diabetes mellitus, 74% had hypertension, 7.1% had atrial fibrillation, 20.1% had cerebrovascular disease, 5.8% had chronic kidney disease, 46.1% had myocardial infarction, and 30.5% had heart failure.

Comparison of baseline data between AKI and non-AKI patients

We divided patients into AKI group (n = 57, 37%) and non-AKI group (n = 97, 63%) to determine whether there were differences in clinical baseline data between the two groups. Compared with the patients in non-AKI group, those in AKI group had higher proportion of chronic kidney disease (2.1% vs. 12.3%, p = 0.009), significantly lower lymphocyte count (1.5 (1.1, 1.9) vs. 1.7 (1.5, 2.1) × 109/L, p = 0.005), higher NLR (2.63 (1.83, 3.505) vs. 2.06 (1.7, 2.56), p = 0.002), higher serum cystatin C (1.195 (0.965, 1.385) vs. 1.01 (0.875, 1.175) mg/L, p = 0.003), higher brain natriuretic peptide (240.9 (108.3, 511.4) vs. 118.2 (47.725, 482.175) pg/ml, p = 0.041), higher serum creatinine (78 (67, 98.5) vs. 70.9 ± 16.8 umol/L, p < 0.001), higher proportion of patients with decreased LVEF (5.7% vs. 29.2%, p < 0.001), longer cardiopulmonary bypass time (125 (108, 130) vs. 114.5 (93, 125) min, p = 0.004), and longer ACC time (68 (58.5, 81) vs. 63 (53, 70.5) min, p = 0.019). However, there was no significant difference between the two groups in terms of age, gender, or comorbidities, including diabetes, hypertension, atrial fibrillation, myocardial infarction, cerebrovascular disease, and heart failure (p > 0.05), while no difference was found between the two groups in terms of white blood cell count, neutrophil count, albumin, blood lipids, uric acid, and ultrasensitive troponin (p > 0.05), as shown in Table 1.
Table 1
Demographic and clinical characteristics of the patients at baseline
Group
No-AKI
AKI
P-value
97
57
Age-no., %
   
≦60 years
33(34.0%)
20(35.1%)
0.893
 > 60 years
64 (66.0%)
37(64.9%)
 
Gender-no., %
  
0.169
 Male
61 (62.9%)
42 (73.7%)
 
 Female
36 (37.1%)
15 (26.2%)
 
Diabetes-no., %
  
0.704
 No
60 (61.9%)
37 (64.9%)
 
 Yes
37 (38.1%)
20 (35.1%)
 
Hypertension-no., %
  
0.492
 No
27 (27.8%)
13 (22.8%)
 
 Yes
70 (72.2%)
44 (77.2%)
 
Previous AF-no., %
  
0.487
 No
89 (91.8%)
54 (94.7%)
 
 Yes
8 (8.2%)
3 (5.3%)
 
Previous stroke-no., %
  
0.827
 No
78 (80.4%)
45 (78.9%)
 
 Yes
19 (19.6%)
12 (21.1%)
 
Previous MI-no., %
  
0.926
 No
52 (53.6%)
31 (54.4%)
 
 Yes
45 (46.4%)
26 (45.6%)
 
CKD-no., %
  
0.009
 No
95 (97.9%)
50(87.7%)
 
 Yes
2 (2.1%)
7 (12.3%)
 
Previous HF-no., %
  
0.345
 No
70 (72.2%)
37 (64.9%)
 
 Yes
27 (27.8%)
20 (35.1%)
 
WBC count,  × 109/L
5.9 ± 1.4
5.9 (5.3, 6.85)
0.477
Neutrophil count,  × 109/L
3.6 ± 1.0
3.9 (3.1, 4.6)
0.101
Lymphocyte count,  × 109/L
1.7 (1.5, 2.1)
1.5 (1.1, 1.9)
0.005
NLR
2.06 (1.7, 2.56)
2.63 (1.83, 3.505)
0.002
Hemoglobin, g/L
129.9 ± 17.7
127.5 ± 18.6
0.557
Albumin, g/L
40 (37, 42)
40.4 ± 4.7
0.383
Serum cystatin C (mg/L)
1.0 1 (0.875, 1.175)
1.195 (0.965, 1.385)
0.003
Serum uric acid (umol/L)
337.2 ± 97.1
364.5 ± 105.2
0.11
Total cholesterol, mmol/L
4.0 ± 1.0
4.1 ± 1.0
0.721
Triglyceride, mmol/L
1.35 (0.9875, 1.8825)
1.515 (1.1375, 2.395)
0.151
LDL, mmol/L
2.04 (1.7025, 2.805)
1.92 (1.6825, 2.575)
0.874
hs-TnI, pg/ml
17.15 (6.525, 82.625)
21.8 (4.7, 96.2)
0.917
BNP, pg/ml
118.2 (47.725, 482.175)
240.9 (108.3, 511.4)
0.041
Serum creatinine, umol/L
70.9 ± 16.8
78 (67, 98.5)
 < 0.001
Anti-hypertensive drugs, N (%)
   
 ACEI
39 (40.2%)
21 (36.8%)
0.0679
 ARB
11 (11.3%)
9 (15.8%)
0.428
Use of Aspirin, N (%)
94 (96.9%)
52 (91.2%)
0.247
Urine output during the cardiopulmonary bypass
900 (600, 1275)
1018 ± 563
0.803
Cardiopulmonary bypass time, min
114.5 (93, 125)
125 (108, 130)
0.004
Aortic clamping time, min
63 (53, 70.5)
68 (58.5, 81)
0.019
Preoperative LVEF (%)-no., %
  
 < 0.001
 ≥ 50
66 (94.3%)
34 (70.8%)
 
 < 50
4 (5.7%)
14 (29.2%)
 
LVEF left ventricular ejection fraction, AKI acute kidney injury, NLR neutrophil-to-lymphocyte ratio, LDL low-density lipoprotein, CKD chronic kidney disease, MI myocardial infarction, AF atrial fibrillation, HF heart failure, hs-TnI high-sensitivity troponin I

Relationship between NLR and postoperative AKI after ONCAB

To clarify the relationship between NLR and postoperative AKI after ONCAB, we further grouped the patients by the tertiles of NLR. The results showed that NLR was higher in patients in Tertile2 compared to those in Tertile1 (2.135 (2, 2.2475) vs. 1.585 (1.345, 1.7225), p < 0.001), also was significantly higher in Tertile3 compared to those in Tertile1 (3.04 (2.7925, 3.6925) vs. 1.585 (1.345, 1.7225), p < 0.001). Compared to patients in Tertile2, NLR was significantly higher in those in Tertile3 (2.135 (2, 2.2475) vs. 3.04 (2.7925, 3.6925), p < 0.001). The distribution of NLR in Tertiles is shown in Fig. 1. We also compared the clinical baseline data of the Tertiles. Leukocyte count, neutrophil count was higher in Tertile2 and Tertile3 patients compared with Tertile1 (p < 0.05), and lymphocyte count was higher in Tertile1 and Tertile2 patients compared to Tertile3 (p < 0.05). We also found a progressively higher percentage (30% vs. 25% vs. 55.8%) and risk of AKI after ONCAB in the three groups (p for trend = 0.003, Fig. 2). When we performed subgroup analysis for those who estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2, this trend still exists, we found that after dividing patient into tertiles based on NLR, those with higher NLR had higher risk of postoperative AKI than those with lower NLR (28.3% vs. 24.4% vs. 50%, p for trend = 0.018).While there was no significant difference among the three groups in age, gender, or comorbidities, including diabetes, hypertension, atrial fibrillation, myocardial infarction, cerebrovascular disease, and heart failure (p > 0.05), and no significant differences (p > 0.05) were found among the three groups in hemoglobin, albumin, blood lipids, ultrasensitive troponin, serum Cystatin C, uric acid, BNP, cardiopulmonary bypass time, ACC time, and cardiac function, as shown in Table 2. Results in Table 1 showed that the occurrence of AKI in patients after ONCAB might be influenced by various aspects. Then we further included the history of chronic kidney disease, lymphocyte count, NLR, serum Cystatin C, serum creatinine, BNP, cardiopulmonary bypass time, ACC time, and LVEF in the multivariate logistic regression analysis, the results showed that patients with higher preoperative NLR had greater risk of AKI [odds ratio (OR) = 4.91, 95% confidential interval (CI) 1.45–16.58, p = 0.0104], and patients with higher preoperative serum creatinine also had greater risk of AKI after surgery (OR = 1.054, 95% CI 1.006–1.105, p = 0.026), as shown in Table 3.
Table 2
Characteristics of 154 patients with on-pump coronary artery bypass by preoperative NLR tertiles
Range of NLR
Tertile1
Tertile2
Tertile3
P value
0.75–1.85
1.85–2.56
2.61–22.6
50
52
52
Age-no., %
   
0.463
 ≦60 years
17 (34.0%)
21 (40.4%)
15 (28.8%)
 
 > 60 years
33 (66.0%)
31 (59.6%)
37 (71.2%)
 
Gender-no., %
   
0.474
 Male
31 (62.0%)
34 (65.4%)
38 (73.1%)
 
 Female
19 (38.0%)
18 (34.6%)
14 (26.9%)
 
Diabetes-no., %
   
0.817
 No
32 (64.0%)
31 (59.6%)
34 (65.4%)
 
 Yes
18 (36.0%)
21 (40.4%)
18 (34.6%)
 
Hypertension-no., %
   
0.187
 No
12 (24.0%)
18 (34.6%)
10 (19.2%)
 
 Yes
38 (76.0%)
34 (65.4%)
42 (80.8%)
 
Previous AF-no., %
   
0.292
 No
47 (94.0%)
46 (88.5%)
50 (96.2%)
 
 Yes
3 (6.0%)
6 (11.5%)
2 (3.8%)
 
Previous Stroke-no., %
   
0.764
 No
40 (80.0%)
43 (82.7%)
40 (76.9%)
 
 Yes
10 (20.0%)
9 (17.3%)
12 (23.1%)
 
Previous MI-no., %
   
0.72
 No
29 (58.0%)
26 (50.0%)
28 (53.8%)
 
 Yes
21 (42.0%)
26 (50.0%)
24 (46.2%)
 
CKD-no., %
   
0.091
 No
49 (98.0%)
50 (96.2%)
46 (88.5%)
 
 Yes
1 (2.0%)
2 (3.8%)
6 (11.5%)
 
Previous HF-no., %
   
0.336
 No
32 (64.0%)
40 (76.9%)
35 (67.3%)
 
 Yes
18 (36.0%)
12 (23.1%)
17 (32.7%)
 
WBC count,  × 109/L
5.5 ± 1.4
6.2 ± 1.1
6.015 (5.3, 7.4)
0.003
Neutrophil count,  × 109/L
2.9 ± 0.9
3.8 ± 0.6
4.2 (3.7, 5.3)
 < 0.001
Lymphocyte count,  × 109/L
2.0 ± 0.5
1.7 (1.6, 1.975)
1.2 (1.1, 1.5)
 < 0.001
NLR
1.585 (1.345, 1.7225)
2.135 (2, 2.2475)
3.04 (2.7925, 3.6925)
 < 0.001
Hemoglobin, g/L
127.2 ± 18.1
132.0 ± 15.2
127.8 ± 20.3
0.411
Albumin, g/L
40 (37, 43)
40.6 ± 4.1
40 (37, 42)
0.42
Serum cystatin C (mg/L)
1.08 (0.91, 1.2)
1.0 ± 0.3
1.2 ± 0.3
0.117
Serum uric acid (umol/L)
349.3 ± 93.2
315.5 (266.75, 382.75)
355.7 ± 91.9
0.314
Total cholesterol, mmol/L
4.1 ± 1.2
4.1 ± 0.8
3.4 (3.0525, 4.2475)
0.135
Triglyceride, mmol/L
1.33 (1.01, 1.85)
1.51 (1.01, 2.39)
1.405 (0.995, 1.965)
0.693
LDL, mmol/L
1.95 (1.6, 2.885)
2.31 (1.92, 2.77)
1.84 (1.5275, 2.51)
0.059
hs-TnI, pg/ml
27.65 (8.175, 76.475)
11.5 (5.775, 54.475)
23.9 (4.3, 123.05)
0.285
BNP, pg/ml
126 (61.7, 477.2)
113.95 (44.775, 408.8)
225.15 (99.55, 583.15)
0.161
Serum creatinine, umol/L
75.5 (68, 90.25)
69.8 ± 17.4
73 (63.25, 90.5)
0.027
Anti-hypertensive drugs, N (%)
    
 ACEI
20 (40%)
16 (30.8%)
24 (46.2%)
0.27
 ARB
8 (16%)
5 (9.6%)
7 (13.5%)
0.627
Use of aspirin, N (%)
49 (98%)
50 (96.2%)
47 (90.4%)
0.20
Urine output during the cardiopulmonary bypass
1000 (600, 1300)
1000 (600, 1500)
900 (500, 1200)
0.512
Cardiopulmonary bypass time, min
124 (103.75, 130.25)
113.5 (90, 125.75)
121 (100, 126)
0.069
Aortic clamping time, min
65 (58, 80)
65.5 (54, 70.75)
63.8 ± 16.8
0.427
AKI-no., %
   
0.002
NO
35 (70.0%)
39 (75.0%)
23 (44.2%)
 
YES
15 (30.0%)
13 (25.0%)
29 (55.8%)
 
Preoperative LVEF (%)-no., %
   
0.092
 ≥ 50
35 (92.1%)
35 (87.5%)
30 (75.0%)
 
 < 50
3 (7.9%)
5 (12.5%)
10 (25.0%)
 
LVEF left ventricular ejection fraction, AKI acute kidney injury, NLR neutrophil-to-lymphocyte ratio, LDL low-density lipoprotein, CKD chronic kidney disease, MI myocardial infarction, AF atrial fibrillation, HF heart failure, hs-TnI high-sensitivity troponin I, CABG coronary artery bypass graft
Table 3
Binary logistic regression of AKI
Variable
Univariable
Multivariable
OR (95% CI)
P
OR (95% CI)
P
CKD(no = 0, yes = 1)
6.6 (1.3–33.2)
0.021
1.12 (0.052–24.44)
0.940
Lymphocyte count,  × 109/L
0.3 (0.2–0.7)
0.005
0.79 (0.12–5.15)
0.802
NLR
2.0 (1.3–2.9)
 < 0.001
4.91 (1.45–16.58)
0.0104
Serum cystatin C (mg/L)
6.9 (1.7–27.8)
0.006
0.48 (0.01–22.82)
0.708
BNP, pg/ml
1.0 (1.0–1.0)
0.161
0.999 (0.997–1.001)
0.406
Serum creatinine, umol/L
1.0 (1.0–1.1)
 < 0.001
1.054 (1.006–1.105)
0.026
Cardiopulmonary bypass time, min
1.0 (1.0–1.0)
0.004
1.034 (0.976–1.095)
0.255
Aortic clamping time, min
1.0 (1.0–1.0)
0.021
1.001 (0.943–1.063)
0.965
LVEF (%) (0 ≥ 50%, 1 < 50%)
6.8 (2.1–22.2)
0.002
3.751 (0.682–20.638)
0.129
LVEF left ventricular ejection fraction, AKI acute kidney injury, NLR neutrophil-to-lymphocyte ratio, CKD chronic kidney disease

Predictive value of NLR for the occurrence of AKI after ONCAB

To clarify the predictive value of NLR for the occurrence of AKI after ONCAB, we performed the analysis using the receiver operator characteristic (ROC) curve, which showed that the area under the curve (AUC) of NLR to predict AKI after ONCAB was 0.6504 (95% CI 0.555–0.7457) with the high specificity of 96.91% but the sensitivity of nearly 36.84%, and the cut-off value was 3.09, this similar trend also exists for those who eGFR more than 60 ml/min/1.73 m2, as shown in Tables 3 and 4. Both univariate and multivariate analyses showed that patients’ preoperative serum creatinine levels (AUC was 0.6678, 95% CI 0.5772–0.7583, cut-off value was 87. 5 umol/L) was also significantly associated with the incidence of postoperative AKI, so the diagnostic efficacy was significantly improved when preoperative NLR and serum creatinine were introduced simultaneously for the combined diagnosis, and the AUC for the diagnosis of postoperative incidence of AKI increased to 0.7233 (95% CI 0.6364–0.8101), with the specificity of 84.54% and the sensitivity of 56.14%, as shown in Fig. 3.
Table 4
Binary logistic regression analysis of AKI with variables and the AUC and optimal threshold of each related variable for those who eGFR ≥ 60 ml/min/1.73 m2
Variable
Univariable regression analysis
AUC and optimal threshold
OR (95% CI)
P
AUC(95% CI)
Optimal threshold
CKD(no = 0, yes = 1)
1.0 (0.1–10.8)
0.971
Lymphocyte count,  × 109/L
0.3 (0.1–0.8)
0.009
0.63 (0.53–0.74)
1.25
NLR
1.9 (1.3–2.9)
0.002
0.64(0.54–0.75)
3.09
Serum cystatin C (mg/L)
5.9 (1.0–33.8)
0.048
0.63 (0.51–0.75)
1.13
Cardiopulmonary bypass time, min
1.0 (1.0–1.0)
0.006
0.65 (0.55–0.75)
114.5
Aortic clamping time, min
1.0 (1.0–1.0)
0.044
0.60 (0.50–0.70)
69.5
eGFR estimated glomerular filtration rate, AKI acute kidney injury, NLR neutrophil-to-lymphocyte ratio, CKD chronic kidney disease, AUC the area under the curve

Discussion

This study retrospectively analyzed the association between preoperative NLR and the incidence of AKI after ONCAB in 154 cases. The results showed that preoperative NLR > 3.09 was an independent predictor of postoperative AKI. We also found that patients with high preoperative serum creatinine levels (> 87.5 umol/L) indicated higher risk of postoperative AKI.
CABG is one of the treatments for coronary atherosclerotic heart disease. In the United States in 2018, 181, 000 cases underwent CABG accounting for 63% of all cardiac surgeries, while in China in 2019 nearly 50, 000 cases CABG [11]. AKI associated with cardiac surgery is a common and serious complication of cardiac surgery under extracorporeal circulation, with some studies showing even up to 40.5% [12]. This also suggests that many patients undergoing CABG may have postoperative AKI without early warning and interventional treatment. Compared to healthy human, AKI patients have 8.8-fold increased risk of progression to chronic kidney disease and 3.3-fold increased risk of progression to end-stage renal disease (ESRD), in addition, more than one-third of patients with AKI in long-term follow-up progress to chronic kidney disease or ESRD [13]. Currently, serum creatinine and urine volume remain the main indicators for the diagnosis of AKI, however, these two indicators often have the lag feature and are of limited value in early diagnosis [14]. Therefore, it is necessary to find ideal biomarkers for the diagnosis of AKI. Unlike neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18, insulin-like growth factor binding protein 7 antibody (IGFBP7), etc., NLR is the combination of neutrophil and lymphocyte counts that is economical and easily available and can be performed in various hospitals. Since inflammation plays an important role in the pathophysiology of AKI, NLR as an inflammatory marker may have the ability to predict AKI [15].
Previous studies have found that alterations in neutrophil and lymphocyte counts and postoperative NLR imbalance are strongly associated with severity of coronary artery disease, poor long-term prognosis, and postoperative complications [16, 17]. Similar to previous research studies, our study showed that increased preoperative NLR was associated with AKI after ONCAB [18]. Increasing neutrophil count is an indicator of active inflammatory process, whereas decreasing lymphocyte count is an indicator of inadequate active inflammatory process. However, individual leukocyte parameter is susceptible to alteration by external conditions (e.g., dehydration, hemodilution, etc.), and NLR is relatively more stable. Elevated NLR reflects the chronic inflammatory state of the body that is exacerbated by extracorporeal circulation and surgery. Although NLR can be obtained simply by routine blood test, there is no consensus to date on the threshold value for NLR. Previous studies suggested the preoperative NLR threshold of 2.65 for predicting AKI after ONCAB alone [18]; similarly, in the present study we found the significant increase in the incidence of AKI with the preoperative NLR > 3.09 after adjusting for confounding factors, which still needs confirmation by large sample studies in the future.
The present study also found that preoperative serum creatinine levels directly influenced the incidence of postoperative AKI. Our results showed that preoperative serum creatinine was significantly higher in patients in the AKI group compared with those in non-AKI group and was positively correlated with the highest blood creatinine value, suggesting that the earlier the onset and the greater the elevation of blood creatinine, the greater the likelihood of AKI. After adjusting other risk factors, high preoperative serum creatinine levels also significantly increased the risk of postoperative AKI, which was consistent with previous studies [8, 19, 20]. Previous studies showed that preoperative serum creatinine ≥ 1.3 mg/dl was an independent risk factor for AKI associated with cardiac surgery, which was largely similar to our results [21].
As one of the important indicators of renal function, increasing serum creatinine before surgery to some extent suggests the concomitant renal insufficiency or reduced renal compensatory capacity, and is prone to induce postoperative hemodynamic flocculation, inflammatory factor release and ischemia–reperfusion injury due to the complexity of CABG, which can further deteriorate renal function. Therefore, it will be of great positive significance for improving prognosis to active monitor renal function after CABG, timely detect abnormal serum creatinine, take appropriate renal protection measures, stop nephrotoxic drugs as early as possible, and correct factors affecting renal perfusion.
Previous studies showed that prolonged cardiopulmonary bypass time and ACC time were also independent risk factors for postoperative complications of AKI in patients undergoing ONCAB [22, 23]. Since renal blood flow and perfusion are relatively insufficient during extracorporeal circulation, massive erythrocytes were destroyed, and the released free hemoglobin consequently caused tubular obstruction and reduced glomerular rate filtration. In addition, blood can also be diluted in extracorporeal circulation and lead to reduced oxygen uptake and renal damage [2426]. Similar to other studies [27], after adjusting confounding factors we did not find a correlation between the cardiopulmonary bypass time and postoperative AKI. This may be related to the short cardiopulmonary bypass time in these patients compared to other studies, which still needs to be confirmed by more studies at a later stage.
There are many limitations in the present research: (i) this is a single-center retrospective study with a small sample size, there is a publication bias, so the results might not be directly extrapolated to other patient groups; (ii) data on C-reactive protein, a common inflammatory index were not collected; (iii) the history of chronic kidney disease were based on self review of patients, and may underestimate the actual incidence rate; (iv) the characteristics of vascular lesions, combined surgery and other factors that may affect the prognosis of surgery were not analyzed. Larger trials are warranted to further substantiate the findings of the present study.
In conclusion, our study showed a high incidence of AKI after ONCAB. An elevated preoperative NLR (> 3.09) and serum creatinine (> 87.5 umol/L) are independent risk factors for postoperative AKI and can serve as an early warning. Early intervention is needed in high-risk patients to reduce the occurrence of AKI to improve long-term prognosis.

Declarations

Conflict of interest

The authors declared that they have no conflicts of interest to disclose.

Ethical approval

This study was approved by the Ethics Committee of Sinopharm Dongfeng General Hospital with number LW-2021–017.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Richards SH, Anderson L, Jenkinson CE, et al. Psychological interventions for coronary heart disease. Cochrane Database of Syst Rev. 2017;4:CD002902. Richards SH, Anderson L, Jenkinson CE, et al. Psychological interventions for coronary heart disease. Cochrane Database of Syst Rev. 2017;4:CD002902.
2.
Zurück zum Zitat Corredor C, Thomson R, Al-Subaie N. Long-term consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):69–75.CrossRef Corredor C, Thomson R, Al-Subaie N. Long-term consequences of acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):69–75.CrossRef
3.
Zurück zum Zitat Takaki S, Shehabi Y, Pickering JW, et al. Perioperative change in creatinine following cardiac surgery with cardiopulmonary bypass is useful in predicting acute kidney injury: a single-centre retrospective cohort study. Interact Cardiovasc Thorac Surg. 2015;21(4):465–9.CrossRef Takaki S, Shehabi Y, Pickering JW, et al. Perioperative change in creatinine following cardiac surgery with cardiopulmonary bypass is useful in predicting acute kidney injury: a single-centre retrospective cohort study. Interact Cardiovasc Thorac Surg. 2015;21(4):465–9.CrossRef
4.
Zurück zum Zitat Chertow GM. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–70.CrossRef Chertow GM. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–70.CrossRef
5.
Zurück zum Zitat Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123(4):1301.CrossRef Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123(4):1301.CrossRef
6.
Zurück zum Zitat Parlar H, Arıkan AA, Önmez A. Dynamic changes in perioperative cellular inflammation and acute kidney injury after coronary artery bypass grafting. Braz J Cardiovasc Surg. 2021;36(3):354–64.CrossRef Parlar H, Arıkan AA, Önmez A. Dynamic changes in perioperative cellular inflammation and acute kidney injury after coronary artery bypass grafting. Braz J Cardiovasc Surg. 2021;36(3):354–64.CrossRef
7.
Zurück zum Zitat Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-to lymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85(4):199–208.CrossRef Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-to lymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85(4):199–208.CrossRef
8.
Zurück zum Zitat Usta S, Abanoz M. Can peroperative neutrophil to lymphocyte ratio change (Deltanlr) Be used as a parameter in predicting acute renal failure following coronary bypass operations with cardiopulmonary bypass? Heart Surg Forum. 2021;24(1):E194–200.CrossRef Usta S, Abanoz M. Can peroperative neutrophil to lymphocyte ratio change (Deltanlr) Be used as a parameter in predicting acute renal failure following coronary bypass operations with cardiopulmonary bypass? Heart Surg Forum. 2021;24(1):E194–200.CrossRef
9.
Zurück zum Zitat Stevens PE, et al. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRef Stevens PE, et al. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRef
10.
Zurück zum Zitat Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.CrossRef Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.CrossRef
11.
Zurück zum Zitat Working Group of the Chinese Expert Consensus on Secondary Prevention after Coronary Artery Bypass Surgery, et al. Chinese Expert Consensus on Secondary Prevention after Coronary Artery Bypass Surgery (2020). Chin J Thorac Cardiovasc Surg. 2021;37(4):193–201. Working Group of the Chinese Expert Consensus on Secondary Prevention after Coronary Artery Bypass Surgery, et al. Chinese Expert Consensus on Secondary Prevention after Coronary Artery Bypass Surgery (2020). Chin J Thorac Cardiovasc Surg. 2021;37(4):193–201.
12.
Zurück zum Zitat Benedetto U, Luciani R, Goracci M, et al. Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery. Ann Thorac Surg. 2009;88(2):529–35.CrossRef Benedetto U, Luciani R, Goracci M, et al. Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery. Ann Thorac Surg. 2009;88(2):529–35.CrossRef
13.
Zurück zum Zitat Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–8.CrossRef Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–8.CrossRef
14.
Zurück zum Zitat Kokkoris S, Pipili C, Grapsa E, et al. Novel biomarkers of acute kidney injury in the general adult ICU: a review. Ren Fail. 2013;35(4):579–91.CrossRef Kokkoris S, Pipili C, Grapsa E, et al. Novel biomarkers of acute kidney injury in the general adult ICU: a review. Ren Fail. 2013;35(4):579–91.CrossRef
15.
Zurück zum Zitat Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189–200.CrossRef Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189–200.CrossRef
16.
Zurück zum Zitat Dey S, Kashav R, Kohli JK, et al. Systemic immune-inflammation index predicts poor outcome after elective off-pump CABG: a retrospective Single-Center Study. J Cardiothorac Vasc Anesth. 2021;35(8):2397–404.CrossRef Dey S, Kashav R, Kohli JK, et al. Systemic immune-inflammation index predicts poor outcome after elective off-pump CABG: a retrospective Single-Center Study. J Cardiothorac Vasc Anesth. 2021;35(8):2397–404.CrossRef
17.
Zurück zum Zitat Gurbuz O, Kumtepe G, Ozkan H, et al. Predictive value of neutrophil-lymphocyte ratio for long-term cardiovascular event following coronary artery bypass grafting. Braz J Cardiovasc Surg. 2020;35(3):274–84.CrossRef Gurbuz O, Kumtepe G, Ozkan H, et al. Predictive value of neutrophil-lymphocyte ratio for long-term cardiovascular event following coronary artery bypass grafting. Braz J Cardiovasc Surg. 2020;35(3):274–84.CrossRef
18.
Zurück zum Zitat Parlar H, Şaşkın H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG? Braz J Cardiovasc Surg. 2018;33(3):233–41.CrossRef Parlar H, Şaşkın H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG? Braz J Cardiovasc Surg. 2018;33(3):233–41.CrossRef
19.
Zurück zum Zitat Yunnan Z, Ming J, Pan Yu, et al. Influencing factors of postoperative acute kidney injury in patients undergoing cardiac surgery. Natl Med J China. 2020;100(012):928–32. Yunnan Z, Ming J, Pan Yu, et al. Influencing factors of postoperative acute kidney injury in patients undergoing cardiac surgery. Natl Med J China. 2020;100(012):928–32.
20.
Zurück zum Zitat Shi Q-x, Han D-n, Ming J, et al. Risk factors of acute kidney injury after cardiopulmonary bypass. Chin J Evid Based Cardiovasc Med. 2017;9(4):452–5. Shi Q-x, Han D-n, Ming J, et al. Risk factors of acute kidney injury after cardiopulmonary bypass. Chin J Evid Based Cardiovasc Med. 2017;9(4):452–5.
21.
Zurück zum Zitat Antunes PE, Prieto D, Ferrão de Oliveira J, et al. Renal dysfunction after myocardial revascularization. Eur J Cardiothorac Surg. 2004;25(4):597–604.CrossRef Antunes PE, Prieto D, Ferrão de Oliveira J, et al. Renal dysfunction after myocardial revascularization. Eur J Cardiothorac Surg. 2004;25(4):597–604.CrossRef
22.
Zurück zum Zitat Ramkumar J, Gopinathan G, Kavin K, et al. Effects of cardiopulmonary bypass perfusion temperature on perioperative renal function in adult patients undergoing cardiac surgery. J Saudi Heart Assoc. 2020;32(1):40–5.PubMedPubMedCentral Ramkumar J, Gopinathan G, Kavin K, et al. Effects of cardiopulmonary bypass perfusion temperature on perioperative renal function in adult patients undergoing cardiac surgery. J Saudi Heart Assoc. 2020;32(1):40–5.PubMedPubMedCentral
23.
Zurück zum Zitat Serraino GF, Provenzano M, Jiritano F, et al. Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery. PLoS ONE. 2021;16(5):e0252209.CrossRef Serraino GF, Provenzano M, Jiritano F, et al. Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery. PLoS ONE. 2021;16(5):e0252209.CrossRef
24.
Zurück zum Zitat Li B, Pan XD, Ma WG, et al. Stented elephant trunk technique for retrograde type A aortic dissection after endovascular stent graft repair. Ann Thorac Surg. 2014;97(2):596–602.CrossRef Li B, Pan XD, Ma WG, et al. Stented elephant trunk technique for retrograde type A aortic dissection after endovascular stent graft repair. Ann Thorac Surg. 2014;97(2):596–602.CrossRef
25.
Zurück zum Zitat Li CH, Leta R, Pons-Lladó G. Myocardial hypoperfusion in acute aortic dissection. Rev Esp Cardiol (Engl Ed). 2014;67(4):323.CrossRef Li CH, Leta R, Pons-Lladó G. Myocardial hypoperfusion in acute aortic dissection. Rev Esp Cardiol (Engl Ed). 2014;67(4):323.CrossRef
26.
Zurück zum Zitat Li L, Zhuang S, Qi S, et al. Acute thoracic aortic dissection (stanford type B) complicated with acute renal failure. Case Rep Vasc Med. 2013;2013:693435.PubMedPubMedCentral Li L, Zhuang S, Qi S, et al. Acute thoracic aortic dissection (stanford type B) complicated with acute renal failure. Case Rep Vasc Med. 2013;2013:693435.PubMedPubMedCentral
27.
Zurück zum Zitat Schopka S, Diez C, Camboni D, et al. Impact of cardiopulmonary bypass on acute kidney injury following coronary artery bypass grafting: a matched pair analysis. J Cardiothorac Surg. 2014;18(9):20.CrossRef Schopka S, Diez C, Camboni D, et al. Impact of cardiopulmonary bypass on acute kidney injury following coronary artery bypass grafting: a matched pair analysis. J Cardiothorac Surg. 2014;18(9):20.CrossRef
Metadaten
Titel
Predictive value of neutrophil to lymphocyte ratio on acute kidney injury after on-pump coronary artery bypass: a retrospective, single-center study
verfasst von
Zhang Guangqing
Cheng Liwei
Ling Fei
Zheng Jianshe
Zeng Guang
Zhu Yan
Cao Jianjun
Tian Ming
Chen Hao
Liu Wei
Publikationsdatum
01.02.2022
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 7/2022
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-022-01772-z

Weitere Artikel der Ausgabe 7/2022

General Thoracic and Cardiovascular Surgery 7/2022 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.